Log In
BCIQ
Print this Print this
 

epinastine HCL (DE-114)

  Manage Alerts
Collapse Summary General Information
Company Santen Pharmaceutical Co. Ltd.
DescriptionHistamine H1 receptor (HRH1) antagonist
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat allergic conjunctivitis; Treat ocular infections
Regulatory Designation Japan - Standard Review (Treat ocular infections)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today